Allergan to Raise Cash Using Debt Securities

Allergan Inc., an Irvine eye- and skin-care company, said Thursday it is planning to raise $300 million using debt securities issued through Merrill Lynch & Co.

The securities, which mature in 20 years, also can be converted to common stock, according to investors looking at the transaction.

Details on what the company would do with the proceeds were not available.